tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating
PremiumRatingsVoyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating
1M ago
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
Premium
Ratings
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
1M ago
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
Premium
The Fly
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
1M ago
Voyager Therapeutics Approves Stock Plans at Annual Meeting
PremiumCompany AnnouncementsVoyager Therapeutics Approves Stock Plans at Annual Meeting
3M ago
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
3M ago
Voyager Therapeutics demonstrates ALPL receptor-mediated BBB transport
Premium
The Fly
Voyager Therapeutics demonstrates ALPL receptor-mediated BBB transport
4M ago
Voyager Therapeutics: Strong Financial Position and Promising Developmental Outlook Justify Buy Rating
PremiumRatingsVoyager Therapeutics: Strong Financial Position and Promising Developmental Outlook Justify Buy Rating
4M ago
Positive FDA Interactions and Strong Financial Position Drive Buy Rating for Voyager Therapeutics
Premium
Ratings
Positive FDA Interactions and Strong Financial Position Drive Buy Rating for Voyager Therapeutics
4M ago
Voyager Therapeutics reports Q1 EPS (53c), consensus (44c)
Premium
The Fly
Voyager Therapeutics reports Q1 EPS (53c), consensus (44c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100